In recent trading session, Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) saw 0.49 million shares changing hands at last check today with its beta currently measuring 2.25.
In the last trading session, 0.39 million shares of the Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) were traded, and its beta was 2.24. Most recently the
In last trading session, Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) saw 0.42 million shares changing hands with its beta currently measuring 2.21. Company’s recent per share
Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) has a beta value of 2.26 and has seen 19.29 million shares traded in the last trading session. The company,
In the last trading session, 1.01 million shares of the Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) were traded, and its beta was 2.26. Most recently the
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne